Archives

  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • br Corresponding author br E mail address kaijiefan

    2020-08-18


    Corresponding author.
    E-mail address: [email protected] (K. Fan). 
    differentiation of human preadipocyte cell line and the expression of adipogenic markers (Boucher et al., 2016). Low dose of BPS exposure during pregnancy can disrupt mouse maternal behaviors and alter function of the lactating mammary gland (Catanese and Vandenberg, 2017). Further, BPS can increase the plasma estrogen levels in hy-pothalamus (Ji et al., 2013). This might be due to that BPS had a comparable estrogenic activity as BPA (Kuruto-Niwa et al., 2005).
    Various studies indicated that BPA can trigger the progression of cancers via promoting cell proliferation, migration, invasion and an-giogenesis (Shafei et al., 2018). Emerging evidences suggested that BPS might also regulate the growth, migration and epithelial mesenchymal transition (EMT) of breast cancer (Deng et al., 2018; Kim et al., 2017) and osteosarcoma (Fic et al., 2015) cells. As one of the leading causes of cancer deaths worldwide, the progression of non-small cell lung cancer (NSCLC) is regulated by estrogen and its related signal pathways (Rodriguez-Lara et al., 2018). BPA can trigger the migration and in-vasion of NSCLC HBX 41108 (Zhang et al., 2014) and disrupt the mouse fetal lung development (Hijazi et al., 2015). Lung cells can be directly ex-posed to BPS via inhalation. However, there is no data about the po-tential effect of BPS on NSCLC progression. Our present study showed that nanomolar BPS can increase the migration and invasion of NSCLC cells via upregulation of transforming growth factor beta (TGF-β).
    Fig. 1. Nanomolar BPS can trigger the migration and invasion of NSCLC cells. (A) A549, H1299, and H358 cells were treated with BPS for 48 h, the proliferation was evaluated by use of CCK-8 kit; A549 (B) or H1299 (C) cells were treated with 1 or 10 nM BPS for 24 h, the wound closure of cells was recorded (left) and statistically analyzed (right); (D) The effects of 10 nM BPS on the migration of A549 and H1299 cells were checked by transwell assay; (E) Cells were treated with or without 10 nM BPS for 24 h, the expression of MMP2, vimentin, fibronectin was measured by western blot analysis (left) and statistically analyzed (right). Data are presented as means ± SD of six independent experiments. *p < .05 compared with control; **p < .01 compared with control.
    2. Materials and methods
    2.1. Chemicals and reagents
    Bisphenol S was purchased from Sigma-Aldrich (St. Louis, MO, USA). All inhibitors including SB431542 (an inhibitor of TGF-β type I receptor kinases), ICI 182780 (an inhibitor of estrogen receptor α/β), G15 (an inhibitor of G protein-coupled estrogen receptor), PD98054 (an inhibitor of ERK1/2), SB203580 (an inhibitor of p38-MAPK), and JNK inhibitor II were purchased from Cell Signaling Technology (Danvers, MA, USA). All compounds were solubilized in DMSO. Medium con-taining 0.5% DMSO was used as the control. Neutralization antibodies for IL-10 and TGF-β were purchased from Bioworld Technology, Inc. (Minneapolis, MN, USA). All primary and horseradish peroxidase-con-jugated secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
    2.2. Cell culture and treatment
    Human NSCLC cell A549 (an adenocarcinomic human alveolar basal epithelial cell, p53+/+, noninvasive, passage 8–20), H1299 (a non-small cell lung cancer epithelial cell, p53−/−, invasive passage 14–25), and H358 (a human bronchiolar lung cancer epithelial cell derived from metastatic site, passage 21–29) cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/ml) and streptomycin (100 mg/ml) at 37 °C under 5% CO2. Twenty-four hours before the experiments, cells were cultured in medium containing no phenol red with charcoal-treated FBS (5% DC-FBS).
    2.3. Analysis of cell proliferation
    Cell proliferation assay was conducted according to the previously
    Fig. 2. BPS increases the expression of TGF-β in NSCLC cells. (A) A549 cells were treated with 10 nM BPS for 24 h, the mRNA expression of various cytokines was checked by qRT-PCR; H1299 (B) or H358 (C) cells were treated with 10 nM BPS for 24 h, the mRNA expression of various cytokines was checked by qRT-PCR; (D) The expression of TGF-β in cells treated with 10 nM BPS for 24 h was checked by ELISA; (E) A549 cells were treated with 10 nM BPS for the indicated time periods, the mRNA of TGF-β was checked by qRT-PCR. Data are presented as means ± SD of six independent experiments. *p < .05 compared with control; **p < .01 compared with control.
    described procedures (Chevalier et al., 2012). Briefly, cells were seeded in 96-well plates for 24 h before exposure to BPS. After treated with increasing concentrations of BPS for 48 h, cell viability was evaluated by use of the CCK-8 kit (Dojindo Molecular Technologies, Gaithers burg, MD, USA) according to the manufacturer's instructions.